| |
| |
|
| Insider
Information: |
Aryeh Jason |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
401,047 |
|
|
Indirect Shares
|
890,847 |
|
|
| Direct
Value |
$7,059,314 |
|
|
|
Indirect Value
|
$4,878,170 |
|
|
| Total
Shares |
1,291,894 |
|
|
| Total
Value |
$11,937,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-11-10 |
4 |
S |
$5.39 |
$60,402 |
I/I |
(11,200) |
206,283 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2023-04-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,246 |
62,984 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-17 |
4 |
S |
$5.94 |
$67,881 |
I/I |
(11,419) |
359,201 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2012-05-21 |
4 |
B |
$2.51 |
$30,060 |
I/I |
12,000 |
520,536 |
2.1 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-10-18 |
4 |
S |
$5.00 |
$60,100 |
I/I |
(12,020) |
232,436 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-13 |
4 |
AS |
$5.49 |
$75,774 |
I/I |
(13,800) |
587,420 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-12 |
4 |
S |
$111.87 |
$1,631,334 |
I/I |
(14,582) |
116,651 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-06 |
4 |
S |
$118.52 |
$1,777,833 |
I/I |
(15,000) |
210,707 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-11-22 |
4 |
S |
$107.40 |
$1,611,065 |
I/I |
(15,001) |
189,376 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-12-27 |
4 |
S |
$5.74 |
$86,634 |
D/D |
(15,093) |
0 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-10 |
4 |
AS |
$5.74 |
$92,414 |
I/I |
(16,100) |
568,120 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-12 |
4 |
S |
$5.93 |
$98,374 |
I/I |
(16,600) |
370,820 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
17,000 |
1,232,650 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-12-29 |
4 |
B |
$2.49 |
$45,996 |
I/I |
18,400 |
461,478 |
2.1 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
179,078 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-09-25 |
4 |
OE |
$6.82 |
$236,584 |
D/D |
20,300 |
53,360 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-11 |
4 |
S |
$110.04 |
$2,494,025 |
I/I |
(22,665) |
131,233 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-02-12 |
4 |
S |
$75.21 |
$1,814,121 |
I/I |
(24,120) |
260,916 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-11-17 |
4 |
S |
$140.22 |
$3,421,368 |
I/I |
(24,400) |
90,251 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2011-03-11 |
4 |
S |
$5.74 |
$142,171 |
I/I |
(24,700) |
140,083 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-12-17 |
4 |
OE |
$5.00 |
$132,500 |
I/I |
25,000 |
486,036 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-02-27 |
4 |
S |
$106.00 |
$2,650,000 |
I/I |
(25,000) |
160,898 |
0 |
- |
|
| MYRX |
Myrexis Inc |
Director |
– • – |
2011-11-23 |
4 |
B |
$2.50 |
$63,620 |
I/I |
25,499 |
161,465 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2010-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,979 |
81,574 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-08-17 |
4 |
S |
$241.81 |
$6,495,559 |
I/I |
(26,862) |
51,392 |
0 |
- |
|
175 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
